SDS-PAGE of rhDDAH1-GST resolving at 58 kDa, and a curve showing L-citrulline produced (nmol) increasing with rhDDAH1-GST concentration (ng/µl) in the ADMA-hydrolysis assay.

Purity and activity of rhDDAH1-GST: SDS-PAGE (left) and ADMA-hydrolysis activity (right), from the product datasheet. Lot-specific values are provided on the COA.

Product details

N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 — an E. coli-expressed, activity-tested enzyme that hydrolyzes ADMA, for nitric-oxide and vascular research.

Specifications
Catalog Number: 4001
Species: Human
Source: E. coli
Amino acids: 2–285
Protein ID: O94760 (DDAH1_HUMAN)
Predicted molecular weight: 58.1 kDa (with GST tag)
SDS-PAGE molecular weight: 58 kDa
Purity: >85% by SDS-PAGE (SimplyBlue SafeStain)
Functional activity: >50 pmol/min/µg (ADMA-hydrolysis assay)
Endotoxin: <1 EU/µg (LAL method)
Formulation: 0.5 mg/mL in 50 mM Tris-HCl pH 8.0, 20 mM reduced glutathione, 1 mM DTT; frozen
Storage & stability: −80 °C in aliquots; 12-month stability. Avoid repeated freeze-thaw.
Intended use: For research use only. Not for use in diagnostic or therapeutic procedures.

Functional activity

Activity-tested at >50 pmol/min/µg in an ADMA-hydrolysis assay. DDAH1 degrades asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric-oxide synthase — supporting studies of vascular function and angiogenesis. Lot-specific activity is provided on the COA.

Scientific background

DDAH1 (dimethylarginine dimethylaminohydrolase 1) hydrolyzes ADMA and N(G)-monomethyl-L-arginine, methylarginines that inhibit nitric-oxide synthase. By clearing ADMA, DDAH1 activity influences nitric-oxide availability, vascular tone and angiogenesis, making it a target of interest in cardiovascular and endothelial research.

Publications using DAPCEL technology and products are listed on the publications page.

See all

Cat. 5003

Recombinant GST

Schistosoma japonicum · expressed in E. coli

from $320.00 3 sizes